Counselor attitudes toward the use of motivational incentives in addiction treatment

American Journal on Addictions

Volumn 19, Issue 6, 2010, Pages 496-503

  Ducharme, Lori J ^a,c   Knudsen, Hannah K ^b   Abraham, Amanda J ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG DEPENDENCE TREATMENT; EDUCATIONAL STATUS; EVIDENCE BASED PRACTICE; HEALTH PERSONNEL ATTITUDE; MEDICAL EDUCATION; MOTIVATION; OPIATE ADDICTION; PATIENT COUNSELING; REWARD; SUBSTANCE ABUSE;

ATTITUDE OF HEALTH PERSONNEL; BEHAVIOR THERAPY; COUNSELING; EVIDENCE-BASED PRACTICE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MOTIVATION; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); REWARD; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 78349234307     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2010.00081.x     Document Type: Article

References (39)

1. Institute of Medicine. Improving the Quality of Health Care for Mental and Substance-Use Disorders: Quality Chasm Series. Washington, DC: National Academy Press; 2006.
2. Lamb S, Greenlick MR, McCarty DE,. Bridging the Gap between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press; 1998.
3. Carroll KM, Rounsaville BJ,. Bridging the gap: A hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv. 2003; 54: 333-339.
4. Cohen WM, Levinthal DA,. Absorptive capacity-A new perspective on learning and innovation. Adm Sci Q. 1990; 35: 128-152.
5. Zahra SA, George G,. Absorptive capacity: A review, reconceptualization, and extension. Acad Manage Rev. 2002; 27: 185-203.
6. Knudsen HK, Roman PM,. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. J Subst Abuse Treat. 2004; 26: 353-361.
7. Ducharme LJ, Knudsen HK, Roman PM, et al,. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. J Subst Abuse Treat. 2007; 32: 321-329.
8. Ducharme LJ, Mello HL, Roman PM, et al,. Service delivery in substance abuse treatment: Reexamining "comprehensive" care. J Behav Health Serv Res. 2007; 34: 121-136.
9. Ducharme LJ, Knudsen HK, Roman PM,. Availability of integrated care for co-occurring substance abuse and psychiatric conditions. Community Ment Health J. 2006; 42: 363-375.
10. Henggeler SW, Chapman JE, Rowland MD, et al,. Statewide adoption and initial implementation of contingency management for substance-abusing adolescents. J Consult Clin Psychol. 2008; 76: 556-567.
11. Petry NM,. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend. 2000; 58: 9-25.
12. Petry NM, Simcic F Jr,. Recent advances in the dissemination of contingency management techniques: Clinical and research perspectives. J Subst Abuse Treat. 2002; 23: 81-86.
13. Griffith JD, Rowan-Szal GA, Roark RR, et al,. Contingency management in outpatient methadone treatment: A meta-analysis. Drug Alcohol Depend. 2000; 58: 55-66.
14. Lussier JP, Heil SH, Mongeon JA, et al,. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006; 101: 192-203.
15. Prendergast M, Podus D, Finney J, et al,. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction. 2006; 101: 1546-1560.
16. Peirce JM, Petry NM, Stitzer ML, et al,. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment-A national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2006; 63: 201-208.
17. Petry NM, Peirce JM, Stitzer ML, et al,. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs-A national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005; 62: 1148-1156.
18. McCarty D, Fuller BE, Arfken C, et al,. Direct care workers in the national drug abuse treatment clinical trials network: Characteristics, opinions, and beliefs. Psychiatr Serv. 2007; 58: 181-190.
19. Herbeck DA, Hser YI, Teruya C,. Empirically supported substance abuse treatment approaches: A survey of treatment providers' perspectives and practices. Addict Behav. 2008; 33: 699-712.
20. Kirby KC, Benishek LA, Dugosh KL, et al,. Substance abuse treatment providers' beliefs and objections regarding contingency management: Implications for dissemination. Drug Alcohol Depend. 2006; 85: 19-27.
21. Knudsen HK, Ducharme LJ, Roman PM,. Research network involvement and addiction treatment center staff: Counselor attitudes toward buprenorphine. Am J Addict. 2007; 16: 365-371.
22. McGovern MP, Fox TS, Xie HY, et al,. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. J Subst Abuse Treat. 2004; 26: 305-312.
23. Haug NA, Shopshire M, Tajima B, et al,. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ. 2008; 38: 181-192.
24. Hanson GR, Leshner AI, Tai B,. Putting drug abuse research to use in real-life settings. J Subst Abuse Treat. 2002; 23: 69-70.
25. Rogers EM,. Diffusion of Innovations. 5th edn. New York: Free Press; 1995.
26. Ducharme LD, Roman PM,. Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption. J Subst Abuse Treat. 2009; 37: 90-94.
27. Knudsen HK, Roman PM,. Racial and ethnic composition as a correlate of medication availability within addiction treatment organizations. Sociol Focus. 2009; 42: 133-151.
28. Forman RF, Bovasso G, Woody G,. Staff beliefs about addiction treatment. J Subst Abuse Treat. 2001; 21: 1-9.
29. Knudsen HK, Johnson JA, Roman PM,. Retaining counseling staff at substance abuse treatment centers: Effects of management practices. J Subst Abuse Treat. 2003; 24: 129-135.
30. Mark TL, Kranzler HR, Song X,. Understanding US addiction physicians' low rate of naltrexone prescription. Drug Alcohol Depend. 2003; 71: 219-228.
31. Kasarabada ND, Hser YI, Parker L, et al,. A self-administered instrument for assessing therapeutic approaches of drug-user treatment counselors. Subst Use Misuse. 2001; 36: 273-299.
32. Long JS, Freese J,. Regression Models for Categorical Dependent Variables Using Stata. College Station, TX: StataCorp; 2003.
33. MacKinnon DP, Dwyer JH,. Estimating mediated effects in prevention studies. Eval Rev. 1993; 17: 144-158.
34. MacKinnon DP, Warsi G, Dwyer JH,. A simulation study of mediated effect measures. Multivariate Behav Res. 1995; 30: 41-62.
35. Baron RM, Kenny DA,. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51: 1173-1182.
36. Preacher KJ, Hayes AF,. SPSS and SAS procedures for estimating indirect effects in mediation models. Behav Res Meth Instrum Comput. 2004; 36: 717-731.
37. Kellogg SH, Burns M, Coleman P, et al,. Something of value: The introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service. J Subst Abuse Treat. 2005; 28: 57-65.
38. Petry NM, Bohn MJ,. Fishbowls and candy bars: Using low-cost incentives to increase treatment retention. Sci Pract Perspect. 2003; 2: 55-61.
39. Sholomskas DE, Syracuse-Siewert G, Rounsaville B, et al,. We don't train in vain: A dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol. 2005; 73: 106-115.